1. Layton AM. A review on the treatment of acne vulgaris. Int J Clin Pract 2006; 60(1): 64-72.

2. Rad F, Yaghmaee R, Ghaderi EB. Comparison of the Therapeutic Efficacy of Azithromycin vs Tetracycline in Acne Vulgaris. Armaghane Danesh 2009; 14(2): 1-8. [in Persian]

3. Stern RS. Acne therapy. medication use and sources of care in office-based practice. Arch Dermatol 1996; 132(7): 776-80.

4. Silverberg NB, Weinberg JM. Rosacea and adult acne: a worldwide epidemic. Cutis 2001; 68(2): 85.

5. Smith RN, Braue A, Varigos GA, Mann NJ. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatological Sci 2008; 50(1): 41-52.

6. Purvis D, Robinson E, Merry S, Watson P. Acne, anxiety, depression and suicide in teenagers: A cross‐sectional survey of New Zealand secondary school students. J Paediatrics Child Health 2006; 42(12): 793-6.

7. Rapp DA, Brenes GA, Feldman SR, Fleischer AB Jr, Graham GF, Dailey M, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 2004; 151(1): 183-9.

8. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr 2007; 86(1): 107-15.

9. Gawkrodger D, Ardern-Jones MR. Dermatology: an illustrated colour text: Elsevier Health Sciences; 2012.

10. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012; 379(9813): 361-72.

11. Thielitz A, Abdel‐Naser MB, Fluhr JW, Zouboulis CC, Gollnick H. Topical retinoids in acne–an evidence‐based overview. J Dtsch Dermatol Ges 2010; 8 Suppl 1: S15-23.

12. Eichenfield LF, Jarratt M, Schlessinger J, Kempers S, Manna V, Hwa J, et al. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol 2010; 9(6): 639-46.

13. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis 2001; 68(4 Suppl): 48-54.

14. Stinco G, Bragadin G, Trotter D, Pillon B, Patrone P. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. J European Academy Dermatol Venereol 2007; 21(3): 320-5.

15. Shapiro S, Heremans A, Mays DA, Martin AL, Hernandez-Medina M, Lanes S. Use of topicaltretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature. J Am Acad Dermatol 2011; 65(6): 1194-201.

16. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142(5): 597-602.

17. Cunliffe WJ, Danby FW, Dunlap F, Gratton D, Greenspan A. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol 2002; 12(4): 350-4.

18. Percy S. Safety and efficacy of adapalene gel 0.1% in acne vulgaris: Results of a post-marketing surveillance study. Indian J Dermatol Venereol Leprol 2003; 69(4): 277.

19. Kellum RE, Strangfeld K. Acne vulgaris. Studies in pathogenesis: Fatty acids of human surface triglycerides from patients with and without acne. J Invest Dermatol 1972; 58(5): 315-8.

20. Logan AC. Linoleic and linolenic acids and acne vulgaris. Br J Dermatol 2008; 158(1): 201-2.

21. Logan AC. Dietary fat, fiber, and acne vulgaris. J Am Acad Dermatol 2007; 57(6): 1092-3.

22. Zhu X, Tu P, Zhen J, Duan Y. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis 2001; 68(4 Suppl): 55-9.

23. Allen BS, Smith JG Jr. Various parameters for grading acne vulgaris. Arch Dermatol 1982; 118(1): 23-5.

24. Magin PJ, Adams J, Heading GS, Pond DC, Smith W. Complementary and alternative medicine therapies in acne, psoriasis, and atopic eczema: results of a qualitative study of patients' experiences and perceptions. J Altern Complement Med 2006; 12(5): 451-7.

25. Weiss JS, Thiboutot DM, Hwa J, Liu Y, Graeber M. Long-term safety and efficacy study of adapalene 0.3% gel. J Drugs Dermatol 2008; 7(6 Suppl): s24-8.

26. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138(12): 1584-90.

27. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2010; 9(1): 59-63.

28. Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 2007; 57(5): 791-9.

29. Phillips TJ. An update on the safety and efficacy of topical retinoids. Cutis 2005; 75(2 Suppl): 14-22.

30. Jain GK, Ahmed FJ. Adapalene pretreatment increases follicular penetration of clindamycin: In vitro and in vivo studies. Indian J Dermatol Venereol Leprol 2007; 73(5): 326.

31. Dréno B, Bettoli V, Ochsendorf F, Layton AM, Perez M, Dakovic R, et al. Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies. Eur J Dermatol 2014; 24(2): 201-9.

32. Tirado‐Sánchez A, Espíndola YS, Ponce‐Olivera RM, Bonifaz A. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single‐center, randomized, double‐blinded, placebo‐controlled clinical trial on Mexican patients (skin type III–IV). J Cosmetic Dermatol 2013; 12(2): 103-7.

33. Jain S. Topical tretinoin or adapalene in acne vulgaris: an overview. J Dermatolog Treat 2004; 15(4): 200-7.

34. Leyden JJ, Shalita A, Thiboutot D, Washenik K, Webster G. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment. Clin Ther 2005; 27(2): 216-24.

35. Ioannides D, Rigopoulos D, Katsambas A. Topical adapalene gel 0• 1% vs. isotretinoin gel 0• 05% in the treatment of acne vulgaris: a randomized open‐label clinical trial. Br J Dermatol 2002; 147(3): 523-7.

36. Ahmed I, Sarwar M. Topical adapalene cream 0.1% v/s isotretinoin 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. J Pakistan Association Dermatol 2016; 19(1): 23-5.